Welcome to On/Go!

Our testing solution combines rapid at-home tests and an easy-to-use mobile app to help you stay healthy, safe and happy. On/Go is the easiest to use and the most reliable.

Install the App!

is a solution like no other

An easy-to-use self-test paired with an intuitive mobile app to deliver accurate results in just 10 minutes.

What is the
On/Go Population Management Platform?

Our AI-powered platform seamlessly integrates with On/Go rapid tests, offering a real-time solution to avoid costly shutdowns through rapid, targeted interventions. To support the fight against COVID-19, our portal provides:


  • Live tracking and viewing of results, by individual or cohort
  • Protocol engine to define groups, routines and interventions
  • Integrated communications to manage messages to individuals or teams

We are excited to offer a smarter COVID solution that enables healthier, happier citizens, an open economy and enhanced peace of mind.

Get a demo

On/Go Self Test

Our technology works seamlessly with the On/Go rapid test

The On/Go test is an over-the-counter, self-administered rapid antigen test that delivers accurate results in just ten minutes, with 95% accuracy. On/Go is effective at detecting all known COVID-19 variants of concern.

Check out the test

The On/Go Experience

Together is Better

The On/Go™ COVID-19 Antigen Self-Test is an over-the-counter, self-performed rapid test for the detection of SARS-CoV-2.  This test is authorized for non-prescription home use by individuals aged 14 years or older or adult collected from individuals aged 2 years or older.  The test is best taken by using the On/Go app, which provides clear, step-by-step instructions for specimen collection and result interpretation.

On/Go For My Business
On/Go For My Family

Disclaimer

This product has not been FDA cleared or approved but has been authorized by FDA under an Emergency Use Authorization (EUA). This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.